Press-release for stocks publishing date 2022 - 08

Prices are updated after-hours

Acasti Pharma Reports First Quarter 2023 Operational Results
Published: 2022-08-11 (Crawled : 01:00) - globenewswire.com
ACST | $3.07 -3.76% -3.91% 9.3K

| -37.12% | O: -0.9% H: 5.16% C: 2.27%
pharma results

aTyr Pharma Receives FDA Fast Track Designation for Efzofitimod (ATYR1923) for Treatment of Pulmonary Sarcoidosis
Published: 2022-08-11 (Crawled : 12:20) - globenewswire.com
LIFE | $1.625 2.2% 2.15% 260K

| -56.57% | O: 1.07% H: 2.65% C: -3.18%
atyr1923 treatment fda designation pharma fast track designation

UroGen Pharma Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
Published: 2022-08-11 (Crawled : 12:20) - biospace.com/
URGN | $14.32 0.56% 0.56% 320K

| 60.83% | O: -6.17% H: 7.42% C: -0.36%
pharma results

Verona Pharma plc Announces Pricing of Upsized Underwritten Public Offering - Aug 11, 2022
Published: 2022-08-11 (Crawled : 07:00) - biospace.com/
VRNA | $16.1 -1.83% -1.86% 490K

| 47.71% | O: 9.17% H: 9.24% C: -0.84%
offering pharma

CinCor Pharma Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
Published: 2022-08-11 (Crawled : 05:00) - globenewswire.com
MS | News | $90.26 0.2% 0.0% 6.7M

| 2.01% | O: 1.23% H: 0.96% C: 0.24%
offering pharma

Verona Pharma plc Announces Pricing of Upsized Underwritten Public Offering
Published: 2022-08-11 (Crawled : 01:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K